Literature DB >> 1373095

Inhibition of neurogenic plasma exudation in guinea-pig airways by CP-96,345, a new non-peptide NK1 receptor antagonist.

Y H Lei1, P J Barnes, D F Rogers.   

Abstract

A new non-peptide tachykinin antagonist, CP-96,345, inhibited airway plasma exudation induced in guinea-pigs by i.v. substance P in a dose-dependent manner with dose-ratios in the main bronchi of 5 at 1 nmol kg-1 and 19 at 100 nmol kg-1. At 100 nmol kg-1, CP-96,345 completely inhibited plasma exudation induced by either electrical stimulation of the cervical vagus nerves or i.v. capsaicin, indicating inhibition of the effects of endogenous tachykinins, but did not inhibit the bronchoconstrictor response to neurokinin A, suggesting selectivity for NK1 receptors. CP-96,345 may be useful in examining the role of endogenous tachykinins in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373095      PMCID: PMC1908658          DOI: 10.1111/j.1476-5381.1992.tb14243.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

1.  Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonist.

Authors:  S McLean; A H Ganong; T F Seeger; D K Bryce; K G Pratt; L S Reynolds; C J Siok; J A Lowe; J Heym
Journal:  Science       Date:  1991-01-25       Impact factor: 47.728

2.  Effects and interactions of sensory neuropeptides on airway microvascular leakage in guinea-pigs.

Authors:  D F Rogers; M G Belvisi; B Aursudkij; T W Evans; P J Barnes
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

3.  Capsaicin-sensitive vagal neurons involved in control of vascular permeability in rat trachea.

Authors:  J M Lundberg; A Saria
Journal:  Acta Physiol Scand       Date:  1982-08

Review 4.  Modulation of neurogenic inflammation: novel approaches to inflammatory disease.

Authors:  P J Barnes; M G Belvisi; D F Rogers
Journal:  Trends Pharmacol Sci       Date:  1990-05       Impact factor: 14.819

Review 5.  The role of increased airway microvascular permeability and plasma exudation in asthma.

Authors:  K F Chung; D F Rogers; P J Barnes; T W Evans
Journal:  Eur Respir J       Date:  1990-03       Impact factor: 16.671

6.  A potent nonpeptide antagonist of the substance P (NK1) receptor.

Authors:  R M Snider; J W Constantine; J A Lowe; K P Longo; W S Lebel; H A Woody; S E Drozda; M C Desai; F J Vinick; R W Spencer
Journal:  Science       Date:  1991-01-25       Impact factor: 47.728

7.  Asthma as an axon reflex.

Authors:  P J Barnes
Journal:  Lancet       Date:  1986-02-01       Impact factor: 79.321

8.  Relative potencies of neurokinins in guinea pig trachea and human bronchus.

Authors:  C Advenier; E Naline; G Drapeau; D Regoli
Journal:  Eur J Pharmacol       Date:  1987-07-09       Impact factor: 4.432

  8 in total
  14 in total

1.  NK1 receptors mediate tachykinin-induced plasma extravasation in the rat knee joint.

Authors:  Y Hirayama; R Yasumitsu; A Kawamura; T Fujii
Journal:  Agents Actions       Date:  1993-11

2.  Substance P contributes to rapidly adapting receptor responses to pulmonary venous congestion in rabbits.

Authors:  A C Bonham; K S Kott; K Ravi; C T Kappagoda; J P Joad
Journal:  J Physiol       Date:  1996-05-15       Impact factor: 5.182

3.  Positive interaction of the beta2-agonist CHF 4226.01 with budesonide in the control of bronchoconstriction induced by acetaldehyde in the guinea-pigs.

Authors:  Giuseppe Rossoni; Barbara Manfredi; Roberta Razzetti; Maurizio Civelli; Stefano Bongrani; Ferruccio Berti
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

4.  NK2 receptors mediate plasma extravasation in guinea-pig lower airways.

Authors:  C Tousignant; C C Chan; D Guevremont; C Brideau; J J Hale; M MacCoss; I W Rodger
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

5.  The non-peptide NK1 receptor antagonist SR140333 produces long-lasting inhibition of neurogenic inflammation, but does not influence acute chemo- or thermonociception in rats.

Authors:  R Amann; R Schuligoi; P Holzer; J Donnerer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

6.  Role played by NK2 receptor and cyclooxygenase activation in bradykinin B2 receptor mediated-airway effects in guinea pigs.

Authors:  T Sakamoto; H Tsukagoshi; P J Barnes; K F Chung
Journal:  Agents Actions       Date:  1993-07

7.  Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea-pigs in vivo.

Authors:  Y Hirayama; Y H Lei; P J Barnes; D F Rogers
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

8.  Involvement of hydroxyl radicals in neurogenic airway plasma exudation and bronchoconstriction in guinea-pigs in vivo.

Authors:  Y H Lei; P J Barnes; D F Rogers
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

9.  Inhibitory activity of the novel CB2 receptor agonist, GW833972A, on guinea-pig and human sensory nerve function in the airways.

Authors:  M G Belvisi; H J Patel; V Freund-Michel; D J Hele; N Crispino; M A Birrell
Journal:  Br J Pharmacol       Date:  2008-08-11       Impact factor: 8.739

10.  Tachykinin receptor antagonists inhibit hyperpnea-induced bronchoconstriction in guinea pigs.

Authors:  J Solway; B M Kao; J E Jordan; B Gitter; I W Rodger; J J Howbert; L E Alger; J Necheles; A R Leff; A Garland
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.